GlassScriptPhysician profile
Daniel B Clarke
NPI 1689719098
$1,820.65
in general payments reported to CMS, 2019-2025
16 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $237 · 2021: $140 · 2022: $80.39 · 2023: $118 · 2024: $487 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $515.49 | 2024-2025 | |
| Alcon Vision LLC | $476.84 | 2019-2025 | Precision 1 |
| Sun Pharmaceutical Industries INC. | $154.98 | 2020-2022 | |
| Rxsight INC | $136.50 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $94.02 | 2019-2023 | |
| Ocular Therapeutix, INC. | $89.45 | 2025 | Dextenza |
| Bausch & Lomb Americas INC. | $88.87 | 2024 | Vyzulta |
| Johnson & Johnson Surgical Vision, INC. | $54.40 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $53.33 | 2019-2023 | Contact Lens, Spectacle Lenses |
| Allergan, INC. | $38.54 | 2020-2021 | |
| Oyster Point Pharma, INC. | $23.92 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $22.23 | 2025 | Xdemvy |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Shire North American Group INC | $18.71 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $17.06 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $16.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Clarke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.